| Name | Title | Contact Details |
|---|---|---|
Douglas Hacker |
Chief Financial Officer | Profile |
Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating cytokine storm via its novel, cutting-edge anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody neutralizati.
LimaCorporate is a medical device company. LimaCorporate’s product range includes Large Joint Primary and Revision implants, Extremities and Fixation solutions and dedicated Patient-Specific prostheses division.
Inotiv: (bio)analytical, in vivo, toxicology and molecular pathology services for preclinical drug metabolism in drug development.
Advarra Integrated Solutions enable the safe, ethical, compliant, and efficient development of life-changing therapies.